This article appears in the following Europace issue: Spotlight Issue: Cardiac Imaging in EP and CRT [View the issue table of contents]
IMAGING IN CATHETER ABLATION FOR AF
Electro-anatomic mapping systems in arrhythmias
1 Department of Cardiology, Pneumology and Vascular Medicine, RWTH University Aachen, Aachen, Germany; 2 German Atrial Fibrillation competence NETwork (AFNET), Germany; 3 Department of Cardiology and Angiology, University Hospital Münster, Albert-Schweitzer-Str. 33, 48149 Muenster, Germany
* Corresponding author. Tel: +49 251 8345185; fax: +49 1212 505521646. E-mail address: kirchhp{at}uni-muenster.de
 |
Abstract |
|---|
 Top Abstract Function and clinical...Electroanatomic mapping systems...Catheter ablation guided by...SummaryFundingReferences |
|---|
Electroanatomic mapping systems have permitted and facilitated difficult interventional ablation procedures for more than a decade. Initially, their use has been in arrhythmias in which the ablation target is difficult to identify, such as ventricular tachycardias in structural heart disease, atypical atrial flutters, or arrhythmias in patients with complex congenital heart defects. In the recent years, electroanatomic mapping systems have also been used to guide catheter-based isolation of the pulmonary veins, an important component of the modern management of atrial fibrillation (AF). Electroanatomic mapping systems integrate three important functionalities, namely (i) non-fluoroscopic localization of electrophysiological catheters in three-dimensional (3D) space; (ii) analysis and 3D display of activation sequences computed from local or calculated electrograms, and 3D display of electrogram voltage (‘scar tissue’); and (iii) integration of this ‘electroanatomic’ information with non-invasive images of the heart (mainly computed tomography or magnetic resonance images). Although better understanding and ablation of complex arrhythmias mostly relies on the 3D integration of catheter localization and electrogram-based information to illustrate re-entrant circuits or areas of focal initiation of arrhythmias, the use of electroanatomic mapping systems in AF is currently based on integration of anatomic images of the left atrium and non-fluoroscopic visualization of the ablation catheter. Their use in the treatment of AF is mainly driven by safety considerations such as shorter fluoroscopy and procedure times, or visualization of cardiac (pulmonary veins) and extra-cardiac (oesophagus) structures that need to be protected during the procedure. In the future, the use of magnetic resonance images, and potentially of high-quality 3D ultrasound images, could provide anatomic information without ionizing radiation and may be helpful to visualize left atrial scar tissue.
Key Words: Electrophysiology, Mapping, Catheter ablation, Atrial fibrillation, Ventricular tachycardia, Image fusion, Echocardiography, Magnetic resonance imaging, Computed tomography
|
Function and clinical development of electroanatomic mapping systems |
|---|
|
TopAbstractFunction and clinical...Electroanatomic mapping systems...Catheter ablation guided by...SummaryFundingReferences |
|---|
Electroanatomic mapping systems have been introduced into clinical electrophysiology over a decade ago.1
,2 In principle, such a system consists of three different parts: (i) non-fluoroscopic catheter localization, (ii) calculation and three-dimensional (3D) display of electrical activation sequences (‘activation maps’) and voltage information (‘voltage maps’) within the cardiac anatomy, and (iii) 3D display of the anatomy of a heart chamber from serially generated catheter localization information. More recently, the systems also allow to display catheter positions and stored electrograms jointly with anatomic information of the target heart chamber generated through other imaging modalities, mainly computed tomography and magnetic resonance tomography. This additional functionality is often referred to as image fusion.
Non-fluoroscopic catheter localization reduces radiation exposure during catheter ablation procedures
Initially, two non-fluoroscopic catheter localization systems were developed, both of which are available today. One system, initially marketed under the name LocaLisa® and currently integrated, e.g. into the NavX® system, uses three low-amplitude high-frequency current fields that are generated in three axes over the patient’s thorax to compute the position of an electrode in the thorax relative to a reference electrode that can be placed in the heart or on the patient’s thorax.2 A similar technique has been implemented in the so-called Ensite® system which is now an integral part of the NavX® platform.3 The other system (CARTO®) uses three magnetic fields that are generated under the patient’s thorax. A magnetosensor that is integrated into the tip of the ablation catheter measures magnetic field strength at the catheter tip and computes the catheter tip position from these measurements.1 On the basis of these measurements, the systems then display the position of any electrophysiology catheter (NavX®) or of any catheter equipped with a magnetosensor (CARTO®) in 3D space. An example of such a catheter localization display is shown in Figure 1.
|
Several groups used either of these non-fluoroscopic catheter visualization techniques to reduce radiation exposure during catheter ablation procedures.4
–6 The capability of both systems to reduce radiation exposure has recently been confirmed in a controlled trial that used both systems head to head.7 Given the small but potentially hazardous effect of ionizing radiation for patients and catheter personnel,8,9 this constitutes an important improvement, especially for time-consuming procedures such as ablation of atrial fibrillation (AF) or ventricular tachycardias.
Analysis of activation sequences by three-dimensional activation maps can guide catheter ablation
The capability of electroanatomic mapping systems to display activation sequences in 3D space has fascinated clinical electrophysiologists. Initially, only the CARTO® system was equipped with a powerful software to analyse and display electrical activation or voltage of local electrograms. Therefore, this system has been used to delineate activation sequences during sinus rhythm or atrial flutter (Figure 2) and has helped to identify critical sites of ventricular and supraventricular arrhythmias in patients with complex congenital heart defects10–12 or in patients with ventricular tachycardias in structural heart disease13–16 and with idiopathic ventricular tachycardias.17,18 Of note, while many users, including the authors, concur that patients with difficult arrhythmias substrates can often only be treated with such a mapping system, the few systematic data that exist do not show a clear effect of electroanatomic mapping systems on ablation success.7
Activation sequences can only be mapped and displayed point by point when the arrhythmia is stable over the time required for mapping. Unstable tachycardias or tachycardias with changing arrhythmia circuits can only be mapped when simultaneous multielectrode recordings can be obtained. The so-called ‘non-contact’ (Ensite®) mapping system records 64 non-contact electrograms from a balloon catheter that is inserted into the heart chamber of interest, whereas a catheter localization system is used to obtain detailed information of the endocardial geometry.3 A complex ‘inverse solution’ mathematical procedure calculates over 3000 simultaneous ‘virtual’ endocardial electrograms from every recorded arrhythmia beat and thereby determines activation sequences. This technique has been used to identify re-entrant circuits in patients with unstable ventricular tachycardias,13,19 to identify scar tissue (see below),20 and occasionally in AF.21
|
Three-dimensional low-voltage maps can identify scar tissue during catheter ablation procedures
Similar to activation maps, voltage of local electrograms can be displayed in 3D space by electroanatomic mapping systems. As low local electrogram voltage is a paramount electrical sign of scar tissue, this feature has been used to identify areas of scar tissue during catheter ablation procedures. Deployment of linear ablation lesions in low-voltage scar areas is an important part of ablation procedures for ventricular tachycardias in structural heart disease.13
,22–25 |
Electroanatomic mapping systems to guide catheter ablation of atrial fibrillation |
|---|
|
TopAbstractFunction and clinical...Electroanatomic mapping systems...Catheter ablation guided by...SummaryFundingReferences |
|---|
Focal triggers of AF in the pulmonary veins or at the junctions between the pulmonary veins and the posterior left atrium26
can be eliminated by catheter-based isolation of the pulmonary veins.27,28 It is interesting to note that almost none of the studies published in this century reports on catheter ablation of AF without some form of electroanatomical mapping or catheter visualization system, mainly driven by safety considerations.29
Use of catheter localization systems for ‘segmental’ isolation of pulmonary veins
Early during the clinical development of pulmonary vein isolation procedures, ‘segmental’ isolation of the pulmonary veins at their ostia has been facilitated by simultaneous visualization of the ablation catheter and of a lasso catheter in the pulmonary vein ostium by non-fluoroscopic continuous catheter visualization. It was felt that such a system cannot only reduce radiation exposure,5 but may also help to avoid pulmonary vein stenoses that are associated with ablation deep within the pulmonary veins. The visualization of left atrial ‘anatomy’ determined through catheter positions at the endocardial surface of the left atrium appears to increase the success rate of the pulmonary vein isolation procedure,30,31 albeit at the price of longer procedure durations.31 More recently (see below), the integration of preprocedural images of the left atrial anatomy into catheter localization systems has facilitated identification of the antral region of the pulmonary veins in the posterior left atrium. Image integration into catheter localization systems appears to be the ‘standard’ approach for catheter-based isolation of the pulmonary veins at present in many specialized centres.
Electrical activation mapping to guide catheter ablation of atrial fibrillation
At present, there are two electrogram- or mapping-based ablation techniques of AF, namely ablation of the so-called ‘continuous fractionated atrial electrograms (CFAE)’ which is advocated by some groups as a first-line treatment for AF,32 and ablation of focal or macro-re-entrant left atrial tachycardias that may arise after catheter-based isolation of the pulmonary veins33–36 or after surgical ablation of AF.37 These procedures make use of all functionalities of electroanatomical mapping systems, i.e. catheter localization, 3D display of electrical activation and/or voltage of local electrograms, and 3D display of anatomic information including image fusion.
Deployment of linear, continuous lesions in the left atrium
Prior to the identification of focal triggers of AF, electrophysiologists had already begun to reproduce surgical compartmentalization of the left atrium, the so-called ‘Cox-Maze’ procedure, with catheter-based techniques.38,39 Linear lesions can be deployed with greater accuracy when electroanatomic mapping systems are used, although the success rate remains low.40 In patients with recurrent AF after electrical isolation of the pulmonary veins,27 linear lesions, ideally with an electrophysiologically proven line of block,41 may be important adjuncts to pulmonary vein isolation in selected patients.42–47 Considerable uncertainty exists as to the type of lesion and the long-term effects of such procedures.27
Fusion of preprocedural anatomic images with intraprocedural catheter localization and intraprocedural anatomic information
The capability to place electrophysiological catheters within ‘virtual’ anatomic images of the heart appears to reduce unwanted side effects during catheter ablation of AF, such as pulmonary vein stenosis42 or thromboembolic complications.43,44 Both, the CARTO® and the NavX® systems allow to integrate either computed tomography or magnetic resonance images of the left atrium into the catheter display image of the mapping system. Currently available registration techniques rely on preprocedural 3D computed tomography or magnetic resonance imaging (MRI) data sets which are aligned with or superimposed to intraprocedural electroanatomical information. Although a reasonable accuracy and usability can be achieved with these techniques, preprocedural anatomic images carry inherent disadvantages: atrial volumes are variable and may change between the imaging session and AF ablation session. Especially in larger atria, the integration error is considerable.45 Furthermore, the contact of the ablation catheter may change atrial geometry. In addition, the true catheter position in relation to the left atrial endocardial surface and changes of the anatomical substrate cannot be visualized and monitored, and lesion formation or development of potential complications cannot be monitored on preprocedural images. Thus, depiction of the ‘real’ anatomy, catheter tissue contact, and lesion formation during the procedure is desirable. However, there are at least two critical requirements for these techniques: at first, excellent soft tissue-contrast is necessary for visualization of the thin atrial walls. Secondly, the imaging system should be compatible with the catheter/mapping system, e.g. there should not be technical interferences between imaging and mapping system. Intracardiac or transoesophageal echocardiography meets these requirements at present. In principle, MRI could also provide such intraprocedural images. Although techniques and concepts for the development of magnetic-resonance compatible catheter systems have been suggested and initiated (see below),46,47 currently, only ultrasound systems are compatible with the available electrophysiology and ablation systems. Intracardiac echocardiography renders comparable image information as MRI.48 Three-dimensional transoesophageal ultrasound systems have already been used to guide catheter-based septal defect closures,49 more recently by the use of a 3D real-time echocardiography system,50 and intracardiac echocardiography images can be reconstructed to yield 3D images of the atria.51 Unfortunately, current 2D or 3D intracardiac or transoesophageal echocardiographic systems only depict partial atrial volumes in real time. Thus, this intraprocedural focused anatomic information will be most useful if integrated with global preprocedural anatomical information of the entire atrium acquired by, for example, computed tomography (Figure 3). Current state of the art is the so-called ‘CARTO® Sound’ system which integrates 2D intracardiac ultrasound information into the CARTO® electroanatomic mapping system.52 Similar developments are under way for the NavX® system.
|
Rotational angiography offers a 3D anatomic visualization technique that may meet many of the needs of intraprocedural anatomic information, although some limitations with respect to tissue visualization and spatial resolution apply (Figure 4).53
|
In summary, although image integration is a fascinating and easily adopted addition to electroanatomical mapping, especially in AF, it has to be appreciated that left atrial anatomy is variable and depends, among other factors, on cardiac rhythm, volume status, respiration, and deformation of the left atrium by electrophysiological catheters during the procedure.45
Image fusion and non-fluoroscopic catheter visualization can therefore probably not fully replace fluoroscopy or other forms of direct catheter visualization during catheter ablation procedures.
Visualization of adjacent anatomical structures
The shift from segmental ostial to antral isolation of the pulmonary veins has reduced the risk of pulmonary vein stenosis, but caused concerns about the rare but potentially fatal risk of thermal damage to the oesophagus,54 at worst with development of atrio-oesophageal fistula.55 Unfortunately, the oesophagus, which can be easily visualized by computed tomography, can move remarkably within the thorax.56,57 Therefore, placement of an electrophysiology catheter or a temperature probe that can be visualized by the electroanatomic mapping system allows to spare the left atrium directly adjacent to the oesophagus during catheter ablation of AF, and may thereby potentially help to prevent oesophageal damage during the procedure.58,59 Other structures that may in the future become of interest for preprocedural imaging include parasympathetic ganglia adjacent to the left atrial wall, which may ultimately become targets for catheter ablation, and the phrenic nerve which can be damaged during catheter ablation near the right-sided pulmonary veins.
|
Catheter ablation guided by magnetic resonance imaging: a glimpse into the future? |
|---|
|
TopAbstractFunction and clinical...Electroanatomic mapping systems...Catheter ablation guided by...SummaryFundingReferences |
|---|
Magnetic resonance imaging of the heart does not require ionizing radiation and poses a reduced risk of renal dysfunction compared with computed tomography; MRI may hence be helpful to minimize radiation exposure during AF ablation procedures that rely on image fusion. Furthermore, ‘delayed contrast media enhancement’ allows to visualize myocardial scars in magnetic resonance images.60
–64 If such techniques are applicable to the visualization of atrial myocardial scarring,65 they may in the future become useful to facilitate (re-) ablation procedures.46 This, however, will require substantial efforts in MR compatible catheter design and development,44,66–69 and considerable changes in the work flow of clinical electrophysiology laboratories. Although the technological perspectives of ablation procedures with a view on the cardiac tissue without ionizing radiation are very attractive, current technology, based on radio frequency energy, fluoroscopy, electroanatomic mapping, and image integration works well and may be ‘hard to beat’. |
Summary |
|---|
|
TopAbstractFunction and clinical...Electroanatomic mapping systems...Catheter ablation guided by...SummaryFundingReferences |
|---|
Electroanatomical mapping systems have three major clinically relevant advantages. They visualize catheter positions in 3D space during the procedure without ionizing radiation. They allow the detailed analysis of arrhythmia mechanisms and to guide ablation procedures in patients with complex arrhythmia substrates. Finally, they allow movement of electrophysiological catheters in a ‘virtual anatomy’ showing the catheter position visualized onto preprocedural and, in the near future, in intraprocedural anatomic images (‘image fusion’). Although the first advantage has been demonstrated in controlled trials, the latter two did so far not undergo rigorous clinical testing.
Conflict of interest: C.K. and P.S. have received travel grants and honoraria from Siemens Medical Systems. P.S. served on advisory boards for Siemens. P.K. has received honoraria or travel grants or served on advisory boards from Medtronic, St Jude Medical, Siemens, and various pharmaceutical companies. P.S. and P.K. have been involved in research on image integration which was partially supported by TomTec imaging systems.
|
Funding |
|---|
|
TopAbstractFunction and clinical...Electroanatomic mapping systems...Catheter ablation guided by...SummaryFundingReferences |
|---|
The preparation of this review paper was funded in part by the German AFNET (projects B7 and B11, German Federal Ministry of Education and Research, 01Gi0204).
|
References |
|---|
|
TopAbstractFunction and clinical...Electroanatomic mapping systems...Catheter ablation guided by...SummaryFundingReferences |
|---|
[1] Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation (1997) 95:1611–22.
[2] Wittkampf F, Wever E, Derksen R, Wilde A, Ramanna H, Hauer R, et al. LocaLisa: new technique for real-time 3-dimensional localization of regular intracardiac electrodes. Circulation (1999) 99:1312–7.
[3] Schilling RJ, Peters NS, Davies DW. Simultaneous endocardial mapping in the human left ventricle using a noncontact catheter: comparison of contact and reconstructed electrograms during sinus rhythm. Circulation (1998) 98:887–98.
[4] Wittkampf FH, Wever EF, Vos K, Geleijns J, Schalij MJ, van der Tol J, et al. Reduction of radiation exposure in the cardiac electrophysiology laboratory. Pacing Clin Electrophysiol (2000) 23:1638–44.[CrossRef][Medline]
[5] Kirchhof P, Loh P, Eckardt L, Ribbing M, Rolf S, Eick O, et al. A novel nonfluoroscopic catheter visualization system (LocaLisa) to reduce radiation exposure during catheter ablation of supraventricular tachycardias. Am J Cardiol (2002) 90:340–3.[CrossRef][Web of Science][Medline]
[6] Kottkamp H, Hugl B, Krauss B, Wetzel U, Fleck A, Schuler G, et al. Electromagnetic versus fluoroscopic mapping of the inferior isthmus for ablation of typical atrial flutter: a prospective randomized study. Circulation (2000) 102:2082–6.
[7] Earley MJ, Showkathali R, Alzetani M, Kistler PM, Gupta D, Abrams DJ, et al. Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J (2006) 27:1223–9.
[8] Calkins H, Niklason L, Sousa J, el-Atassi R, Langberg J, Morady F. Radiation exposure during radiofrequency catheter ablation of accessory atrioventricular connections. Circulation (1991) 84:2376–82.
[9] Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet (2004) 363:345–51.[CrossRef][Web of Science][Medline]
[10] Nakagawa H, Shah N, Matsudaira K, Overholt E, Chandrasekaran K, Beckman KJ, et al. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow ‘focal’ ablation. Circulation (2001) 103:699–709.
[11] Zeppenfeld K, Schalij MJ, Bartelings MM, Tedrow UB, Koplan BA, Soejima K, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation (2007) 116:2241–52.
[12] de Groot NM, Zeppenfeld K, Wijffels MC, Chan WK, Blom NA, Van der Wall EE, et al. Ablation of focal atrial arrhythmia in patients with congenital heart defects after surgery: role of circumscribed areas with heterogeneous conduction. Heart Rhythm (2006) 3:526–35.[CrossRef][Web of Science][Medline]
[13] Klemm HU, Ventura R, Steven D, Johnsen C, Rostock T, Lutomsky B, et al. Catheter ablation of multiple ventricular tachycardias after myocardial infarction guided by combined contact and noncontact mapping. Circulation (2007) 115:2697–704.
[14] Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation (2003) 108:704–10.
[15] Soejima K, Stevenson WG, Maisel WH, Sapp JL, Epstein LM. Electrically unexcitable scar mapping based on pacing threshold for identification of the reentry circuit isthmus: feasibility for guiding ventricular tachycardia ablation. Circulation (2002) 106:1678–83.
[16] Marchlinski FE, Zado E, Dixit S, Gerstenfeld E, Callans DJ, Hsia H, et al. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation (2004) 110:2293–8.
[17] Sager PT, Behboodikhah M. A nonfluoroscopic catheter-based mapping technique to ablate focal ventricular tachycardia. Pacing Clin Electrophysiol (1998) 7:1442–7.
[18] Ribbing M, Wasmer K, Mönnig G, Kirchhof P, Loh P, Breithardt G, et al. Endocardial mapping of right ventricular outflow tract tachycardia using noncontact activation mapping. J Cardiovasc Electrophysiol (2003) 14:602–8.[CrossRef][Web of Science][Medline]
[19] Schilling RJ, Peters NS, Davies DW. Feasibility of a noncontact catheter for endocardial mapping of human ventricular tachycardia. Circulation (1999) 99:2543–52.
[20] Voss F, Steen H, Bauer A, Giannitsis E, Katus HA, Becker R. Determination of myocardial infarct size by noncontact mapping. Heart Rhythm (2008) 5:308–14.[CrossRef][Web of Science][Medline]
[21] Schilling RJ, Kadish AH, Peters NS, Goldberger J, Davies DW. Endocardial mapping of atrial fibrillation in the human right atrium using a non-contact catheter. Eur Heart J (2000) 21:550–64.
[22] Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation (2000) 101:1288–96.
[23] Brunckhorst CB, Delacretaz E, Soejima K, Maisel WH, Friedman PL, Stevenson WG. Identification of the ventricular tachycardia isthmus after infarction by pace mapping. Circulation (2004) 110:652–9.
[24] Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation (2008) 117:462–9.
[25] Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 357:2657–65.
[26] Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 339:659–66.
[27] Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace (2007) 9:335–79.
[28] Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace (2006) 8:651–745.
[29] Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace (2007) 9:1006–23.
[30] Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT, et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation (2005) 111:127–35.
[31] Ernst S, Antz M, Ouyang F, Vogtmann T, Goya M, Bansch D, et al. Ostial PV isolation: is there a role for three-dimensional mapping? Pacing Clin Electrophysiol (2003) 26:1624–30.[CrossRef][Medline]
[32] Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol (2004) 43:2044–53.
[33] Ouyang F, Ernst S, Vogtmann T, Goya M, Volkmer M, Schaumann A, et al. Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence. Circulation (2002) 105:1934–42.
[34] Shah D, Sunthorn H, Burri H, Gentil-Baron P, Pruvot E, Schlaepfer J, et al. Narrow, slow-conducting isthmus dependent left atrial reentry developing after ablation for atrial fibrillation: ECG characterization and elimination by focal RF ablation. J Cardiovasc Electrophysiol (2006) 17:508–15.[CrossRef][Web of Science][Medline]
[35] Gerstenfeld EP, Dixit S, Bala R, Callans DJ, Lin D, Sauer W, et al. Surface electrocardiogram characteristics of atrial tachycardias occurring after pulmonary vein isolation. Heart Rhythm (2007) 4:1136–43.[CrossRef][Web of Science][Medline]
[36] Sanders P, Hocini M, Jais P, Hsu LF, Takahashi Y, Rotter M, et al. Characterization of focal atrial tachycardia using high-density mapping. J Am Coll Cardiol (2005) 46:2088–99.
[37] Magnano AR, Argenziano M, Dizon JM, Vigilance D, Williams M, Yegen H, et al. Mechanisms of atrial tachyarrhythmias following surgical atrial fibrillation ablation. J Cardiovasc Electrophysiol (2006) 17:366–73.[CrossRef][Web of Science][Medline]
[38] Baker BM, Smith JM, Cain ME. Nonpharmacologic approaches to the treatment of atrial fibrillation and atrial flutter. J Cardiovasc Electrophysiol (1995) 6:972–8.[Web of Science][Medline]
[39] Haissaguerre M, Jais P, Shah DC, Gencel L, Pradeau V, Garrigues S, et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (1996) 7:1132–44.[Web of Science][Medline]
[40] Ernst S, Schluter M, Ouyang F, Khanedani A, Cappato R, Hebe J, et al. Modification of the substrate for maintenance of idiopathic human atrial fibrillation: efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation (1999) 100:2085–92.
[41] Gaita F, Riccardi R, Caponi D, Shah D, Garberoglio L, Vivalda L, et al. Linear cryoablation of the left atrium versus pulmonary vein cryoisolation in patients with permanent atrial fibrillation and valvular heart disease: correlation of electroanatomic mapping and long-term clinical results. Circulation (2005) 111:136–42.
[42] Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 111:1100–5.
[43] Dong J, Calkins H, Solomon SB, Lai S, Dalal D, Lardo AC, et al. Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations. Circulation (2006) 113:186–94.
[44] Tops LF, Bax JJ, Zeppenfeld K, Jongbloed MR, Lamb HJ, van der Wall EE, et al. Fusion of multislice computed tomography imaging with three-dimensional electroanatomic mapping to guide radiofrequency catheter ablation procedures. Heart Rhythm (2005) 2:1076–81.[CrossRef][Web of Science][Medline]
[45] Heist EK, Chevalier J, Holmvang G, Singh JP, Ellinor PT, Milan DJ, et al. Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of atrial fibrillation. J Interv Card Electrophysiol (2006) 17:21–7.[Web of Science][Medline]
[46] Nazarian S, Kolandaivelu A, Zviman MM, Meininger GR, Kato R, Susil RC, et al. Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies. Circulation (2008) 118:223–9.
[47] Dickfeld T, Calkins H, Zviman M, Kato R, Meininger G, Lickfett L, et al. Anatomic stereotactic catheter ablation on three-dimensional magnetic resonance images in real time. Circulation (2003) 108:2407–13.
[48] Zanchetta M, Rigatelli G, Pedon L, Zennaro M, Dimopoulous K, Onorato E, et al. Intracardiac echocardiography: gross anatomy and magnetic resonance correlations and validations. Int J Cardiovasc Imaging (2005) 21:391–401.[CrossRef][Web of Science][Medline]
[49] Zanchetta M, Rigatelli G, Pedon L, Zennaro M, Carrozza A, Onorato E. Catheter closure of perforated secundum atrial septal defect under intracardiac echocardiographic guidance using a single amplatzer device: feasibility of a new method. J Invasive Cardiol (2005) 17:262–5.[Medline]
[50] Balzer J, Kuhl H, Franke A. Real-time three-dimensional transesophageal echocardiography for guidance of atrial septal defect closures. Eur Heart J (2008) March 13 [Epub ahead of print].
[51] Knackstedt C, Franke A, Mischke K, Zarse M, Gramley F, Schimpf T, et al. Semi-automated 3-dimensional intracardiac echocardiography: development and initial clinical experience of a new system to guide ablation procedures. Heart Rhythm (2006) 3:1453–9.[CrossRef][Web of Science][Medline]
[52] Khaykin Y, Klemm O, Verma A. First human experience with real-time integration of intracardiac echocardiography and 3D electroanatomical imaging to guide right free wall accessory pathway ablation. Europace (2007) doi:10.1093/europace/eum243.
[53] Orlov MV, Hoffmeister P, Chaudhry GM, Almasry I, Gijsbers GH, Swack T, et al. Three-dimensional rotational angiography of the left atrium and esophagus—a virtual computed tomography scan in the electrophysiology lab? Heart Rhythm (2007) 4:37–43.[CrossRef][Web of Science][Medline]
[54] Doll N, Borger MA, Fabricius A, Stephan S, Gummert J, Mohr FW, et al. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J Thorac Cardiovasc Surg (2003) 125:836–42.
[55] Bunch TJ, Nelson J, Foley T, Allison S, Crandall BG, Osborn JS, et al. Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol (2006) 17:435–9.[CrossRef][Web of Science][Medline]
[56] Lemola K, Sneider M, Desjardins B, Case I, Han J, Good E, et al. Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation. Circulation (2004) 110:3655–60.
[57] Monnig G, Wessling J, Juergens KU, Milberg P, Ribbing M, Fischbach R, et al. Further evidence of a close anatomical relation between the oesophagus and pulmonary veins. Europace (2005) 7:540–5.
[58] Shah BK, Yarlagadda RK, Tan V, Lerman BB. Three-dimensional identification of the esophagus during ablation of atrial fibrillation. Heart Rhythm (2005) 2:565.[CrossRef][Web of Science][Medline]
[59] Sherzer AI, Feigenblum DY, Kulkarni S, Pina JW, Casey JL, Salka KA, et al. Continuous nonfluoroscopic localization of the esophagus during radiofrequency catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2007) 18:157–60.[CrossRef][Web of Science][Medline]
[60] Ashikaga H, Sasano T, Dong J, Zviman MM, Evers R, Hopenfeld B, et al. Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res (2007) 101:939–47.
[61] Reddy VY, Malchano ZJ, Holmvang G, Schmidt EJ, d'Avila A, Houghtaling C, et al. Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. J Am Coll Cardiol (2004) 44:2202–13.
[62] Perin EC, Silva GV, Sarmento-Leite R, Sousa AL, Howell M, Muthupillai R, et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation (2002) 106:957–61.
[63] Ramani K, Judd RM, Holly TA, Parrish TB, Rigolin VH, Parker MA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation (1998) 98:2687–94.
[64] Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol (2005) 45:285–92.
[65] Dong J, Dickfeld T, Dalal D, Cheema A, Vasamreddy CR, Henrikson CA, et al. Initial experience in the use of integrated electroanatomic mapping with three-dimensional MR/CT images to guide catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 17:459–66.[CrossRef][Web of Science][Medline]
[66] Brooks AG, Wilson L, Kuklik P, Stiles MK, John B, Shashidhar, et al. Image integration using NavX Fusion: initial experience and validation. Heart Rhythm (2008) 5:526–35.[CrossRef][Web of Science][Medline]
[67] Dong J, Dalal D, Scherr D, Cheema A, Nazarian S, Bilchick K, et al. Impact of heart rhythm status on registration accuracy of the left atrium for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2007) 18:1269–76.[CrossRef][Web of Science][Medline]
[68] Kistler PM, Rajappan K, Jahngir M, Earley MJ, Harris S, Abrams D, et al. The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 17:1093–101.[CrossRef][Web of Science][Medline]
[69] Malchano ZJ, Neuzil P, Cury RC, Holmvang G, Weichet J, Schmidt EJ, et al. Integration of cardiac CT/MR imaging with three-dimensional electroanatomical mapping to guide catheter manipulation in the left atrium: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 17:1221–9.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Kirchhof, M. Ozgun, S. Zellerhoff, G. Monnig, L. Eckardt, K. Wasmer, W. Heindel, G. Breithardt, and D. Maintz Diastolic isthmus length and 'vertical' isthmus angulation identify patients with difficult catheter ablation of typical atrial flutter: a pre-procedural MRI study Europace, January 1, 2009; 11(1): 42 - 47. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||